Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
26.48
+0.28 (1.07%)
At close: Jan 23, 2026, 4:00 PM EST
26.50
+0.02 (0.08%)
After-hours: Jan 23, 2026, 6:18 PM EST
AAPG Market Cap
AAPG has a market cap or net worth of $2.4 billion as of January 23, 2026. Its market cap has increased by 37.92% in one year.
Market Cap
2.40B
Enterprise Value
2.41B
1-Year Change
37.92%
Ranking
Category
Stock Price
$26.48
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $2.40B, an increase of 333.35%. That is a compound annual growth rate of 50.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 2.40B | -2.77% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
| Jun 13, 2022 | 554.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 2.55B |
| Travere Therapeutics | 2.53B |
| Mineralys Therapeutics | 2.48B |
| Ocular Therapeutix | 2.43B |
| Telix Pharmaceuticals | 2.43B |
| Recursion Pharmaceuticals | 2.40B |
| Soleno Therapeutics | 2.34B |
| Sarepta Therapeutics | 2.24B |